Toward a Core Domain Set for Glucocorticoid Impact in Inflammatory Rheumatic Diseases: The OMERACT 2018 Glucocorticoid Impact Working Group.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 30647165.
- Also identified by DOI 10.3899/jrheum.181082 and PMC identifier 6629524.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To understand the effects of glucocorticoids (GC), which are of importance to patients. The results of 2 literature reviews, a patient survey, and a qualitative study were presented. No validated instrument exists to evaluate GC effect on patients. Survey data revealed skin thinning/bruising, sleep disturbance, and weight gain as the most frequent adverse effects. The qualitative research yielded rich data covering rapid benefits and physical and emotional consequences of GC. It was agreed that a patient-reported outcome to measure GC effect was required and a research agenda was developed for this goal.
Medical subject headings
- Glucocorticoids
- Rheumatic Diseases